Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick G Morris

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Cancer|June 18, 2011
Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancerHeather L McArthur, Kathleen M Mahoney, Patrick G Morris, et al.
BMC Cancer|February 9, 2021
One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centreRachel J Keogh, Razia Aslam, Maeve A Hennessy, et al.
Irish Journal of Medical Science|August 20, 2020
Lack of familiarity with genetic testing among patients in Ireland with CancerWilliam J Mullally, Fergus Keane, Amy Nolan, et al.
Frontiers in Medicine|January 9, 2023
Case report: <i>BRAF</i>-inhibitor therapy in <i>BRAF</i>-mutated primary CNS tumours including one case of <i>BRAF</i>-mutated <i>Rosai-Dorfman</i> diseaseChristopher Cronin, Ronan McLaughlin, Louise Lane, et al.
Leukemia & Lymphoma|June 25, 2011
Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapyPatrick G Morris, Lauren E Abrey, Anne S Reiner, et al.
Cancer Discovery|May 12, 2012
Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese womenKotha Subbaramaiah, Patrick G Morris, Xi Kathy Zhou, et al.
Clinical Breast Cancer|February 6, 2010
Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan resultsPatrick G Morris, Catherine Van Poznak, Shanu Modi, et al.
Irish Journal of Medical Science|January 17, 2022
The cost of cancer care: how far would you go for a trial?Orla M Fitzpatrick, Catherine Murphy, Erica Duignan, et al.
Cancer Medicine|January 10, 2014
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancerGary A Ulaner, Anne Eaton, Patrick G Morris, et al.
Molecular Oncology|August 25, 2014
Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective studyLeonardo Tenori, Catherine Oakman, Patrick G Morris, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Cancer|June 18, 2011
Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancerHeather L McArthur, Kathleen M Mahoney, Patrick G Morris, et al.
BMC Cancer|February 9, 2021
One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centreRachel J Keogh, Razia Aslam, Maeve A Hennessy, et al.
Irish Journal of Medical Science|August 20, 2020
Lack of familiarity with genetic testing among patients in Ireland with CancerWilliam J Mullally, Fergus Keane, Amy Nolan, et al.
Frontiers in Medicine|January 9, 2023
Case report: <i>BRAF</i>-inhibitor therapy in <i>BRAF</i>-mutated primary CNS tumours including one case of <i>BRAF</i>-mutated <i>Rosai-Dorfman</i> diseaseChristopher Cronin, Ronan McLaughlin, Louise Lane, et al.
Leukemia & Lymphoma|June 25, 2011
Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapyPatrick G Morris, Lauren E Abrey, Anne S Reiner, et al.
Cancer Discovery|May 12, 2012
Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese womenKotha Subbaramaiah, Patrick G Morris, Xi Kathy Zhou, et al.
Clinical Breast Cancer|February 6, 2010
Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan resultsPatrick G Morris, Catherine Van Poznak, Shanu Modi, et al.
Irish Journal of Medical Science|January 17, 2022
The cost of cancer care: how far would you go for a trial?Orla M Fitzpatrick, Catherine Murphy, Erica Duignan, et al.
Cancer Medicine|January 10, 2014
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancerGary A Ulaner, Anne Eaton, Patrick G Morris, et al.
Molecular Oncology|August 25, 2014
Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective studyLeonardo Tenori, Catherine Oakman, Patrick G Morris, et al.
Pageof 10